Literature DB >> 15613086

Purification and mass spectroscopic analysis of human CB2 cannabinoid receptor expressed in the baculovirus system.

S Filppula1, S Yaddanapudi, R Mercier, W Xu, S Pavlopoulos, A Makriyannis.   

Abstract

The cannabinergic system is present in a variety of organs and tissues that perform a wide range of essential physiologic functions making it an inherently important therapeutic target for drug discovery. In order to augment our knowledge regarding the interactions between cannabinoid receptors (CBs) and their ligands, efficient and effective tools are essential for robust expression and purification of these membrane-bound proteins. In this report, we describe a suitable method for purification of the human cannabinoid receptor 2 (CB2) to a qualitative and quantitative level sufficient for mass spectral analysis. We utilized a baculovirus expression system, incorporating several epitope tags to facilitate purification and to ameliorate the effect the tags have on CB2 expression and function. Expressed protein encoded by a carboxy (C)-terminal His-tagged CB2 construct displayed a B(max) value of 9.3 pmol/mg with a K(D) of 7.30 nM using [3(H)]CP-55(940), a standard cannabinoid radioligand, and was selected for subsequent purification experiments. Western blot analysis of purified membrane protein yielded several forms of CB2, the most abundant being a 41 kDa peptide. A second protein species was observed with an apparent molecular weight of 46 kDa representing a glycosylated form of CB2. In addition, a CB2 homodimer was also identified. The purified receptor was subjected to mass spectroscopic analysis to confirm its identity and purity. Mass spectra corresponding to the intracellular, extracellular and transmembrane domains were obtained. These experiments exemplify the importance of high-level expression systems when developing membrane-bound protein purification strategies. This work will aid in the identification of receptor-ligand binding sites, the characterization of molecular features involved in receptor activation, and the elucidation of the CB2 receptor tertiary structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613086     DOI: 10.1111/j.1399-3011.2004.00188.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  10 in total

1.  2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Authors:  Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

2.  Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation.

Authors:  Dennis W Szymanski; Malvina Papanastasiou; Katja Melchior; Nikolai Zvonok; Richard W Mercier; David R Janero; Ganesh A Thakur; Sangwon Cha; Billy Wu; Barry Karger; Alexandros Makriyannis
Journal:  J Proteome Res       Date:  2011-09-13       Impact factor: 4.466

3.  Analysis of a G protein-coupled receptor for neurotensin by liquid chromatography-electrospray ionization-mass spectrometry.

Authors:  Jenny T C Ho; Jim F White; Reinhard Grisshammer; Sonja Hess
Journal:  Anal Biochem       Date:  2007-12-27       Impact factor: 3.365

4.  Efficient digestion and mass spectral analysis of vesicular glutamate transporter 1: a recombinant membrane protein expressed in yeast.

Authors:  Holly D Cox; Chih-Kai Chao; Sarjubhai A Patel; Charles M Thompson
Journal:  J Proteome Res       Date:  2008-01-08       Impact factor: 4.466

5.  Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.

Authors:  Bruno Cécyre; Sébastien Thomas; Maurice Ptito; Christian Casanova; Jean-François Bouchard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-05       Impact factor: 3.000

6.  Stabilization of functional recombinant cannabinoid receptor CB(2) in detergent micelles and lipid bilayers.

Authors:  Krishna Vukoti; Tomohiro Kimura; Laura Macke; Klaus Gawrisch; Alexei Yeliseev
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

7.  Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity.

Authors:  Yannick Marchalant; Philip W Brownjohn; Amandine Bonnet; Torsten Kleffmann; John C Ashton
Journal:  J Histochem Cytochem       Date:  2014-03-26       Impact factor: 2.479

8.  Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells.

Authors:  Marjolein Soethoudt; Sara C Stolze; Matthias V Westphal; Luuk van Stralen; Andrea Martella; Eva J van Rooden; Wolfgang Guba; Zoltan V Varga; Hui Deng; Sander I van Kasteren; Uwe Grether; Adriaan P IJzerman; Pal Pacher; Erick M Carreira; Herman S Overkleeft; Andreea Ioan-Facsinay; Laura H Heitman; Mario van der Stelt
Journal:  J Am Chem Soc       Date:  2018-02-16       Impact factor: 15.419

Review 9.  An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors.

Authors:  Paula Morales; Patricia H Reggio
Journal:  Cannabis Cannabinoid Res       Date:  2017-10-01

10.  Receptor and channel heteromers as pain targets.

Authors:  Kelly A Berg; Amol M Patwardhan; Armen N Akopian
Journal:  Pharmaceuticals (Basel)       Date:  2012-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.